A Clinical Study to Investigate the Effects of an Infant Formula Containing Partially Hydrolysed Proteins on Growth, Safety and Tolerance in Healthy Term Infants

PHASE2CompletedINTERVENTIONAL
Enrollment

380

Participants

Timeline

Start Date

April 27, 2017

Primary Completion Date

October 26, 2018

Study Completion Date

November 12, 2018

Conditions
Growth
Interventions
OTHER

Infant Formula with prebiotics

Intervention group: Partially hydrolysed whey protein based infant formula containing prebiotics.

OTHER

Standard Infant Formula

Control group: Intact cow's milk protein based infant formula containing prebiotics

Trial Locations (15)

Unknown

University of Turku Children's Allergy and Asthma Clinic, Turku

Groupement des Hopitaux de l'institut Catholique de Lille, Lille

Hospices Civils de Lyon, Lyon

Vivantes Klinik für Geburtsmedizin, Klinikum Neukölln, Berlin

Paediatric Practice, Bramsche

Gelre Ziekenhuizen, Apeldoorn

Poliklinika Ginekologiczno-Poloznicza Sp. z o.o. Sp.k, Bialystok

Specjalistyczna Poradnia Medyczna Przylądek Zdrowia, Krakow

POLMED / Instytut Mikroekologii, Poznan

Korczowski Bartosz, Gabinet Lekarski, Rzeszów

NZLA Michalkowice Jarosz i Partnerzy Spolka Lekarska, Siemianowice Śląskie

Hospital Quirónsalud Barcelona, Barcelona

Hospital General Universitario de Elche, Elche

Hospital Universitari Sant Joan de Reus (IISPV), Reus

Hospital Universitari de Tarragona Joan XXIII, Tarragona

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Nutricia Research

INDUSTRY